Insider Activity of Chanda Sanjay
According to the SEC Form 4 filings, Chanda Sanjay, being in a position of
- Chief Development Officer at AN2 Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 2957 shares for $3,965,over all time since 2025-01-03, has bought 0 shares, and sold 2957 shares for $3,965.
The largest sale of all time was on 2025-01-03 and amounted to 2957 shares of AN2 Therapeutics, Inc. for $3,965.
Biography of Chanda Sanjay
No biography is available at this moment.